Showing 2481-2490 of 4590 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21006/A Multidisciplinary Toolbox for Atopic Dermatitis Treatments
https://practicaldermatology.com/topics/atopic-dermatitis/a-multidisciplinary-toolbox-for-atopic-dermatitis-treatments/23445/New Products/New In My Practice: Devices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-devices/23177/Currents: Skin of Color
https://practicaldermatology.com/topics/skin-of-color/currents-1/22985/Continuity of Psoriasis Care in the Era of COVID-19
https://practicaldermatology.com/columns/clinical-focus-1/continuity-of-psoriasis-care-in-the-era-of-covid-19/23285/While there’s no data about susceptibility to COVID-19 in psoriasis, there is relevant information on infectious complications from biologics.Currents
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/currents-6/23145/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-14/23289/The Future of Treatment and Research for Giant Congenital Melanocytic Nevi
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-future-of-treatment-and-research-for-giant-congenital-melanocytic-nevi/57252/Congenital melanocytic nevi (CMN) have long posed a clinical paradox: lesions that are often benign in behavior yet burdened by a measurable risk of melanoma and significant psychosocial impact. Present at birth or emerging in early infancy, CMN vary widely in size, distribution, and long-term impliKybella Off-Label?
https://practicaldermatology.com/topics/practice-management/kybellaoff-label/21057/Experts weigh in on whether and how Kybella® may be used off-label.Evolution in Dermatology/Industry Partnerships
https://practicaldermatology.com/topics/practice-management/evolution-in-dermatologyindustry-partnerships/23295/The COVID-19 crisis is changing the dermatology industry. What does it mean?